Transgene Expression in the Mouse Lung following Administration of Gene Transfer Vectors Expressing EGFP. (2004)

Davies, L. A., Varathalingam, A., Cheng, S. H., Hyde, S. C. & Gill, D. R.

Journal of Cystic Fibrosis, 3, S29

Download   Back

The murine lung has served as a model for the evaluation of a variety of gene therapy vectors for cystic fibrosis lung disease. Many studies have focussed on enhancing overall gene expression in the lung but few have examined if expression can be demonstrated in the ciliated epithelial cells believed to be the major target for cystic fibrosis gene therapy. We evaluated transgene expression in the murine lung using vectors incorporating the red-shifted variant of green fluorescent protein (EGFP). BALB/c mice were dosed intranasally with 300µg of the plasmid pEGFP-N1 or 80µg of pEGFP-N1 complexed to the cationic lipid GL67 (Genzyme, Framingham, USA). 24 hours after vector administration, 7µm cryosections were prepared from lung tissues and examined for GFP expression. GFP positive cells were identified in all treated mice with a mean expression of 347±280 positive cells in sections from animals dosed with pEGFP-N1. The majority (79%) of these cells were located in the epithelium of conducting airways and the remainder (21%) were located in the lung parenchyma. Subsequent immunohistochemical analysis revealed that most of these GFP positive cells were ciliated epithelial cells. In mice treated with DNA/GL67, 2,020 ±435 GFP positive cells per mouse were observed. In contrast to naked DNA the majority (99.4%) of GFP positive cells were located in the lung parenchyma and only a very small number (0.6%) were observed in the conducting airway epithelium. Antibody staining demonstrated that the majority of GFP positive cells in mice treated with DNA/GL67 were Type I pneumocytes. These data reflect that GFP expression is a robust first step in the detection and identification of cell types targeted by gene transfer vectors in the mouse lung.

Home
News
Introductory Videos
Medical Futures Innovation Award 2011
Twitter Feed
About Us
Contact Us
Careers
Resources
Lab Events
Environemental Policy
About this Site

Google Site Search

Site Feedback Form

All Site Images

 

UK CFGTC

How the Consortium works/FAQs

Consortium Website

Centre for Molecular Medicine, Edinburgh
The Roslin Institute
Dep of Gene Therapy, Imperial

Milestones

GL67A/pGM169

The Run-in Study

Single Dose Clinical Trial

Multi Dose Clinical Trial

 

Our Research

Non-viral Vector Development

Aerosol Mediated Gene Delivery

Viral Vector Development

Taqman Core Facility

Cystic Fibrosis

History of CF

Discovery of the CFTR Gene

CFTR Protein Structure

CFTR Function

CF Links

 

Gene Therapy

Introduction to Gene Therapy

Other CF Gene Therapy Groups

Why use Gene Therapy for CF

Target Cells for CF Gene Therapy

Barriers for CF Gene Therapy

Clinical Trials

Gene Therapy Successes

Gene Therapy Links

 

 

Publications

Papers in Journals

Conference Posters & Presentations

Book Chapters

D.Phil Theses

Lectures

 

Gene Therapy Seminars

Schedule

Directions & Venue